Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.19
+0.06 (0.54%)
At close: Sep 4, 2026, 4:00 PM EDT
11.30
+0.11 (0.98%)
After-hours: Sep 4, 2026, 7:45 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $547.08 million as of September 4, 2026. Its market cap has increased by 604.33% in one year.
Market Cap
547.08M
Enterprise Value
207.54M
1-Year Change
604.33%
Ranking
Category
Stock Price
$11.19
ChartMarket Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $547.08M, an increase of 209.51%. That is a compound annual growth rate of 70.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 547.08M | 419.56% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 590.16M |
| Cabaletta Bio | 588.32M |
| Eikon Therapeutics | 588.23M |
| Prelude Therapeutics | 562.35M |
| ARS Pharmaceuticals | 558.89M |
| Eupraxia Pharmaceuticals | 554.49M |
| Ovid Therapeutics | 546.83M |
| Capricor Therapeutics | 546.51M |